{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:45:58Z","timestamp":1784940358232,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003598","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T00:00:00Z","timestamp":1247011200000}}],"reference-count":291,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003598.pub2","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T10:47:01Z","timestamp":1246618021000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Antihypertensive treatment for kidney transplant recipients"],"prefix":"10.1002","author":[{"given":"Nicholas B","family":"Cross","sequence":"first","affiliation":[{"name":"Christchurch Public Hospital; Department of Nephrology; Private Bag 4710 Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela C","family":"Webster","sequence":"additional","affiliation":[{"name":"(c) School of Public Health, University of Sydney; (a) Cochrane Renal Group, Centre for Kidney Research, The Children's Hospital at Westmead, (b) Centre for Transplant and Renal Research, Westmead Millennium Institute, University of Sydney at Westmead Hospital; Edward Ford Building A27 Sydney NSW Australia 2006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Masson","sequence":"additional","affiliation":[{"name":"Royal Infirmary of Edinburgh; Department of Renal Medicine; Edinburgh Scotland UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"O'Connell","sequence":"additional","affiliation":[{"name":"University of Sydney at Westmead Hospital; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"(b) School of Public Health, The University of Sydney; (a) Cochrane Renal Group, Centre for Kidney Research, The Children's Hospital at Westmead; Locked Bag 4001 Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0001|cit1","first-page":"2383","article-title":"Effect of diltiazem in the prevention of acute tubular necrosis, acute rejection, and cyclosporine levels","volume":"23","author":"Alcaraz","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0002|cit2","first-page":"50","article-title":"Influence of the calcium blocker diltiazem on the prevention of acute renal failure after renal transplantation","volume":"24","author":"Oppenheimer","year":"1992","journal-title":"Transplantation Proceedings"},{"issue":"7-8","key":"10.1002\/14651858.CD003598.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1016\/S0041-1345(01)02450-2","article-title":"Is losartan as effective as enalapril on posttransplant persistent proteinuria?","volume":"33","author":"Altiparmak","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.transproceed.2006.08.066","article-title":"Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study","volume":"38","author":"Andres","year":"2006","journal-title":"Transplantation Proceedings"},{"issue":"Sept","key":"10.1002\/14651858.CD003598.pub2-BIB0005|cit5","first-page":"692A","article-title":"Valsartan is effective in patients with post-transplant hypertension [abstract]","volume":"11","author":"Jardine","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0006|cit6","first-page":"S193","article-title":"A randomised trial of effects of AT1-rezeptor- vs. calcium-channel-blockade on arterial function in hypertensive renal transplant recipients [abstract]","volume":"126","author":"Barenbrock","year":"2001","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub2-BIB0007|cit7","first-page":"S196","article-title":"Studies of effects of antihypertensive treatment by AT1-receptor- vs. calcium-channel-blockade on sympathetic nerve activity in renal transplant recipients [abstract]","volume":"126","author":"Kosch","year":"2001","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0008|cit8","first-page":"1072","article-title":"Isradipine (ISR) in the treatment of hypertension in renal transplant patients (RTP) on cyclosporin (CSA): a randomized open-label cross-over study [abstract]","volume":"6","author":"Barri","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0009|cit9","first-page":"1035","article-title":"Use of ACE inhibitors to control transplant erythrocytosis [abstract]","volume":"8","author":"Beckingham","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD003598.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/ndt\/10.12.2316","article-title":"A randomized placebo-controlled study of enalapril in the treatment of erythrocytosis after renal transplantation","volume":"10","author":"Beckingham","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0011|cit11","first-page":"730","article-title":"A randomized placebo-controlled study of enalapril in post-transplant erythrocytosis [abstract]","volume":"10","author":"Woodrow","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000186262","article-title":"Interaction between ciclosporin and diltiazem in renal transplant patients","volume":"57","author":"Campistol","year":"1991","journal-title":"Nephron"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0013|cit13","first-page":"881A","article-title":"Double blind, crossover, comparative study of doxazosin vs enalapril in the treatment of hypertension in renal transplantation under cyclosporin immunosuppression [abstract]","volume":"12","author":"Castelao","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0041-1345(01)02818-4","article-title":"Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression","volume":"34","author":"Martinez-Castelao","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000045819","article-title":"Comparison of enalapril and losartan in the treatment of posttransplant erythrocytosis","volume":"86","author":"Celik","year":"2000","journal-title":"Nephron"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0016|cit16","first-page":"A292","article-title":"Enalapril and losartan on the treatment of posttransplantation erythrocytosis [abstract]","volume":"14","author":"Celik","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/ndt\/gfg341","article-title":"Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients","volume":"18","author":"Chanard","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0018|cit18","first-page":"882A","article-title":"Amlodipine reduces cyclosporine-induced hyperuricemia in hypertensive renal transplant recipients [abstract]","volume":"12","author":"Chanard","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00007890-199302000-00014","article-title":"Diltiazem in renal allograft recipients receiving cyclosporine","volume":"55","author":"Chrysostomou","year":"1993","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0020|cit20","first-page":"2127","article-title":"A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results","volume":"22","author":"Kelly","year":"1990","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0021|cit21","first-page":"1379","article-title":"Verapamil prevents posttransplant delayed function and cyclosporine A nephrotoxicity","volume":"22","author":"Dawidson","year":"1990","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1681\/ASN.V25983","article-title":"Verapamil improves the outcome after cadaver renal transplantation","volume":"2","author":"Dawidson","year":"1991","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003598.pub2-BIB0023|cit23","first-page":"500","article-title":"Losartan could prevent progression of chronic allograft nephropathy: a prospective randomized study [abstract]","volume":"18","author":"Agroudy","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000072820","article-title":"Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients","volume":"23","author":"Agroudy","year":"2003","journal-title":"American Journal of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003598.pub2-BIB0025|cit25","first-page":"500","article-title":"Losartan could prevent progression of chronic allograft nephropathy: a prospective randomized study [abstract]","volume":"18","author":"Agroudy","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000072820","article-title":"Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients","volume":"23","author":"Agroudy","year":"2003","journal-title":"American Journal of Nephrology"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003598.pub2-BIB0027|cit27","first-page":"200","article-title":"A randomized controlled trial comparing losartan to amlodipine as initial therapy for hypertension in the immediate post transplant period [abstract]","volume":"5","author":"Formica","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/ndt\/gfk058","article-title":"A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period","volume":"21","author":"Formica","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00005344-199006166-00004","article-title":"Calcium channel blockers for kidney protection","volume":"16 Suppl 6","author":"Frei","year":"1990","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0030|cit30","first-page":"3539","article-title":"Preoperative graft reperfusion with a calcium antagonist improves initial function: preliminary results of a prospective randomized trial in 110 kidney recipients","volume":"19","author":"Frei","year":"1987","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0041-1345(02)03059-2","article-title":"A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients","volume":"34","author":"Gossmann","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0032|cit32","first-page":"1114","article-title":"A randomized, double blind, placebo controlled study of gallo-pamil in cyclosporine treated renal transplant recipients [abstract]","volume":"6","author":"Scheuermann","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/00365599.1984.11783718","article-title":"Angiotensin I-converting enzyme inhibition after renal transplantation","volume":"79","author":"Gronhagen-Riska","year":"1984","journal-title":"Scandinavian Journal of Urology & Nephrology Supplementum"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0034|cit34","first-page":"1223","article-title":"Effects of diltiazem on arterial pressure and renal function in renal transplanted and cyclosporin A treated subjects. Results after 3 months of a prospective study","volume":"82","author":"Guerin","year":"1989","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1399-0012.2007.00643.x","article-title":"Enalapril\/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial","volume":"21","author":"Halimi","year":"2007","journal-title":"Clinical Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0036|cit36","first-page":"445","article-title":"Effect of nifedipine on immediate graft function on cyclosporin-treated renal transplant patients: a prospective randomized study","volume":"79","author":"Donnelly","year":"1992","journal-title":"British Journal of Surgery"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD003598.pub2-BIB0037|cit37","first-page":"600","article-title":"Renal transplantation: nifedipine for the nonstarters? A prospective randomised study","volume":"25","author":"Donnelly","year":"1993","journal-title":"Transplantation Proceedings"},{"issue":"12","key":"10.1002\/14651858.CD003598.pub2-BIB0038|cit38","first-page":"2387","article-title":"Beneficial effects of oral nifedipine on cyclos(CsA)-treated renal transplant recipients [abstract]","volume":"10","author":"Harper","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Harper SJ Harris K Jurewicz A Walls J Veitch P Feehally J Beneficial effects of oral nifedipine on cyclosporin (cya) treated renal allograft recipients - a randomised prospective study [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain) 1995 381","DOI":"10.1111\/j.1432-2277.1996.tb00865.x"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1432-2277.1996.tb00865.x","article-title":"The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients--a randomised prospective study","volume":"9","author":"Harper","year":"1996","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00007890-199210000-00037","article-title":"Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients--a randomized prospective study","volume":"54","author":"Harper","year":"1992","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1111\/tri.1992.5.s1.69","article-title":"Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients","volume":"5 Suppl 1","author":"Harper","year":"1992","journal-title":"Transplant International"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub2-BIB0043|cit43","first-page":"904","article-title":"Protective effects of nifedipine in immediate and 6-month graft function in cyclosporin A treated renal allograft recipients [abstract]","volume":"6","author":"Harper","year":"1991","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jcp.47.9.839","article-title":"Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A","volume":"47","author":"McCulloch","year":"1994","journal-title":"Journal of Clinical Pathology"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1111\/j.1432-2277.1994.tb01380.x","article-title":"Cyclosporin, nifedipine and gingival hyperplasia: a randomized controlled study","volume":"7 Suppl 1","author":"Morgan","year":"1994","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0046|cit46","unstructured":"Hausberg M Barenbrock M Hohage H Heidenreich S Rahn KH Efficacy and safety of the ace-inhibitor quinapril as compared to the beta-blocker atenolol in hypertensive renal allograft recipients [abstract] 35th Congress European Renal Association. European Dialysis and Transplantation Association; 1998 Jun 6-9; Rimini (Italy) 1998 359"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/01.HYP.33.3.862","article-title":"ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients","volume":"33","author":"Hausberg","year":"1999","journal-title":"Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0002-9149(00)01024-9","article-title":"Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation","volume":"86","author":"Suwelack","year":"2000","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0041-1345(02)03058-0","article-title":"Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition","volume":"34","author":"Suwelack","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2003.tb00306.x","article-title":"Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients","volume":"16","author":"Suwelack","year":"2003","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0051|cit51","doi-asserted-by":"crossref","unstructured":"Suwelack B Witta J Hausberg M Barenbrock M Rahn KH Arterial vessel wall hypertrophy in renal transplant recipients: effects of ace inhibitor and b - blocker treatment [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998 Jun 6-9; Rimini (Italy) 1998 195","DOI":"10.1097\/00007890-199805131-00585"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0054|cit52","first-page":"1041","article-title":"Effect of captopril on post-transplant erythrocytosis: a controlled study [abstract]","volume":"8","author":"Hernandez","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0052|cit53","first-page":"2239","article-title":"Usefulness and safety of treatment with captopril in posttransplant erythrocytosis","volume":"27","author":"Hernandez","year":"1995","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0053|cit54","first-page":"940","article-title":"Usefulness of treatment with captopril on post-transplant erythrocytosis (PTE). A controlled study [abstract]","volume":"4","author":"Hernandez","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0055|cit55","first-page":"708A","article-title":"Regression of left ventricular hypertrophy (LVH) by lisinopril after renal transplantation (RT). Role of angiotensin-converting-enzyme (ACE) gene polymorphism [abstract]","volume":"9","author":"Hernandez","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0056|cit56","first-page":"714A","article-title":"Regression of left ventricular hypertrophy (LVH) by an angiotensin-converting-enzyme inhibitor (ACEI) after renal transplantation (RT) [abstract]","volume":"8","author":"Hernandez","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1523-1755.2000.00239.x","article-title":"Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism","volume":"58","author":"Hernandez","year":"2000","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Inigo P Campistol JM Lario S Bescos M Oppenheimer F Losartan normalizes the plasma levels of TGF-\u00df1 in a random, crossover study (losartan vs. amlodipine) in renal transplant patients treated with CsA [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome (Italy) 2000","DOI":"10.1097\/00007890-200004271-01112"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1681\/ASN.V124822","article-title":"Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients","volume":"12","author":"Inigo","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0060|cit60","doi-asserted-by":"crossref","unstructured":"Inigo P Campistol JM Piera C Oppenheimer F Effects on renal hemodynamics of losartan vs. amlodipine in a cross-over trial in renal transplant patients [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome (Italy) 2000","DOI":"10.1097\/00007890-200004271-00671"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0061|cit61","first-page":"759A","article-title":"Losartan normalizes the plasma levels of tgf-b1 in a random, crossover study (losartan vs amlodipine) in renal transplant patients treated with cyclosporine[abstract]","volume":"10","author":"Inigo","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub2-BIB0062|cit62","first-page":"324","article-title":"The effect of enalapril on the progression of chronic allograft nephropathy. [abstract]","volume":"17","author":"Kim","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2125.2003.01908.x","article-title":"Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin","volume":"56","author":"Kumana","year":"2003","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"Oct","key":"10.1002\/14651858.CD003598.pub2-BIB0064|cit64","first-page":"526A","article-title":"Calcium channel blockade and preservation of renal allograft function in cyclosporine-treated recipients: a multicentre, prospective randomized, placebo-controlled, 2-year study. [abstract]","volume":"15","author":"Kuypers","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.TP.0000137793.23371.42","article-title":"Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study","volume":"78","author":"Kuypers","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD003598.pub2-BIB0066|cit66","first-page":"432","article-title":"Calcium channel blockade and prevention of renal graft function deterioration in cyclosporine-treated recipients: a multi-centre prospective, randomized, placebo-controlled, 2-year study. [abstract]","volume":"4","author":"Kuypers","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/9.5.543","article-title":"Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study","volume":"9","author":"Ladefoged","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0068|cit68","first-page":"A276","article-title":"A randomised placebo controlled study on initial isradipine therapy in renal transplantation: long-term results [abstract]","volume":"15","author":"Lehtonen","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0069|cit69","first-page":"1102","article-title":"Ciclosporine nephrotoxicity can be counteracted by a calcium antagonist (felodipine) in acute and short-term studies [abstract]","volume":"6","author":"Madsen","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/ndt\/13.9.2327","article-title":"The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation","volume":"13","author":"Madsen","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0071|cit71","first-page":"S94","article-title":"Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies","volume":"49","author":"Madsen","year":"1996","journal-title":"Kidney International - Supplement"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1399-0012.2005.00416.x","article-title":"Predictors of health-related quality of life in hypertensive recipients following renal transplantation","volume":"19","author":"Aasebo","year":"2005","journal-title":"Clinical Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/ndt\/16.7.1465","article-title":"Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients","volume":"16","author":"Asberg","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0074|cit74","first-page":"737A","article-title":"Improved long-term graft function and fewer rejection episodes in hypertensive renal transplant patients treated with nifedipine as compared to lisinopril","volume":"10","author":"Midtvedt","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00007890-200112150-00013","article-title":"Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1034\/j.1399-0012.2001.150611.x","article-title":"Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial","volume":"15","author":"Midtvedt","year":"2001","journal-title":"Clinical Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0077|cit77","first-page":"907A","article-title":"Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a 2 year prospective randomized double-blind single centre study [abstract]","volume":"12","author":"Midtvedt","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0078|cit78","first-page":"A308","article-title":"Nifedipine slow release reduces the incidence of acute rejections in hypertensive renal transplant recipients [abstract]","volume":"14","author":"Midtvedt","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007890-200107150-00021","article-title":"Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0080|cit80","first-page":"1733","article-title":"Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study","volume":"22","author":"Morales","year":"1990","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub2-BIB0081|cit81","first-page":"1537","article-title":"Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial","volume":"21","author":"Morales","year":"1989","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0085|cit82","first-page":"832","article-title":"Calcium antagonist therapy prevents chronic cyclosporin nephrotoxicity after renal transplantation: A prospective study [abstract]","volume":"6","author":"Morales","year":"1991","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0082|cit83","first-page":"950","article-title":"Long-term protective effect of calcium antagonist (CA) on renal function in hypertensive renal transplant (RT) patients on ciclosporine (CyA) therapy. a five-year prospective randomized study [abstract]","volume":"4","author":"Morales","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0083|cit84","first-page":"880","article-title":"Beneficial effects of calcium antagonists on cyclosporin nephrotoxicity after clinical renal transplantation","volume":"8","author":"Morales","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0084|cit85","first-page":"89","article-title":"Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study","volume":"24","author":"Morales","year":"1992","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0086|cit86","first-page":"2598","article-title":"Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study","volume":"26","author":"Morales","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ki.1993.61","article-title":"Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants","volume":"43","author":"Mourad","year":"1993","journal-title":"Kidney International"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0089|cit88","first-page":"1070","article-title":"Comparison of enalapril and theophylline treatment for posttransplant erythrocytosis (PTE) [abstract]","volume":"10","author":"Ok","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub2-BIB0088|cit89","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/00007890-199506000-00021","article-title":"Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation","volume":"59","author":"Ok","year":"1995","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2007.04.013","article-title":"ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial","volume":"50","author":"Paoletti","year":"2007","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00007890-199403270-00021","article-title":"A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome","volume":"57","author":"Patton","year":"1994","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0272-6386(12)81092-4","article-title":"A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients","volume":"21","author":"Pirsch","year":"1993","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0093|cit93","unstructured":"Barenbrock M Breuer J Schroder K Wagner K Neumayer HH Rahn KH A study of the nephroprotective effect of nitrendipine after renal transplantation [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain) 1995 387"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0094|cit94","first-page":"388","article-title":"A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function","volume":"43","author":"Barenbrock","year":"1995","journal-title":"Clinical Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0095|cit95","first-page":"1466","article-title":"Effect of nitrendipine on kidney function after renal transplantation [abstract]","volume":"11","author":"Barenbrock","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9188","key":"10.1002\/14651858.CD003598.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(99)08421-4","article-title":"Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial","volume":"354","author":"Rahn","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/ndt\/12.7.1441","article-title":"Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation","volume":"12","author":"Rockstroh","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0098|cit98","unstructured":"Barenbrock M Breuer J Schroder K Wagner K Neumayer HH Rahn KH A study of the nephroprotective effect of nitrendipine after renal transplantation [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain) 1995 387"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0099|cit99","first-page":"388","article-title":"A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function","volume":"43","author":"Barenbrock","year":"1995","journal-title":"Clinical Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0100|cit100","first-page":"1466","article-title":"Effect of nitrendipine on kidney function after renal transplantation [abstract]","volume":"11","author":"Barenbrock","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9188","key":"10.1002\/14651858.CD003598.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(99)08421-4","article-title":"Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial","volume":"354","author":"Rahn","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/ndt\/12.7.1441","article-title":"Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation","volume":"12","author":"Rockstroh","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0103|cit103","unstructured":"Barenbrock M Breuer J Schroder K Wagner K Neumayer HH Rahn KH A study of the nephroprotective effect of nitrendipine after renal transplantation [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain) 1995 387"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0104|cit104","first-page":"388","article-title":"A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function","volume":"43","author":"Barenbrock","year":"1995","journal-title":"Clinical Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0105|cit105","first-page":"1466","article-title":"Effect of nitrendipine on kidney function after renal transplantation [abstract]","volume":"11","author":"Barenbrock","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9188","key":"10.1002\/14651858.CD003598.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(99)08421-4","article-title":"Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial","volume":"354","author":"Rahn","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/ndt\/12.7.1441","article-title":"Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation","volume":"12","author":"Rockstroh","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.transproceed.2007.11.033","article-title":"Effects of losartan and enalapril on high-sensitivity C-reactive protein and total antioxidant in renal transplant recipients with Renin-Angiotensin system polymorphisms","volume":"40","author":"Argani","year":"2008","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10157-007-0001-x","article-title":"Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms","volume":"12","author":"Ghorbanihaghjo","year":"2008","journal-title":"Clinical & Experimental Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.transproceed.2007.02.016","article-title":"Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril","volume":"39","author":"Noroozianavval","year":"2007","journal-title":"Transplantation Proceedings"},{"issue":"3-4","key":"10.1002\/14651858.CD003598.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.clinbiochem.2006.10.023","article-title":"Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms","volume":"40","author":"Rashtchizadeh","year":"2007","journal-title":"Clinical Biochemistry"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00004872-200018080-00017","article-title":"Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients","volume":"18","author":"Rump","year":"2000","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0113|cit113","unstructured":"Santos AF Keitel E Bittar A Neto JP Alves MD Schaefer PG Long term results of diltiazem use associated to cyclosporin in renal transplantation [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA) 2002"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ndt\/16.5.1034","article-title":"The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA","volume":"16","author":"Schmidt","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0115|cit115","unstructured":"Schmidt A Gruber U Bohmig G Koller E Mayer G The effect of ace inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with cyclosporin [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome (Italy) 2000"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0116|cit116","first-page":"746A","article-title":"The effect of ace inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homestasis in hypertensive renal transplant recipients treated with cyclosporin A [abstract]","volume":"10","author":"Schmidt","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.HYP.26.3.436","article-title":"Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients","volume":"26","author":"Sennesael","year":"1995","journal-title":"Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0272-6386(96)90106-7","article-title":"Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients","volume":"27","author":"Sennesael","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF03044784","article-title":"Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients","volume":"92","author":"Sperschneider","year":"1997","journal-title":"Medizinische Klinik"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0120|cit120","first-page":"707A","article-title":"Influence of diltiazem on cyclosporine metabolites in renal graft recipients treated with Sandimmun and Neoral [abstract]","volume":"8","author":"Wagner","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF03044784","article-title":"Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients","volume":"92","author":"Sperschneider","year":"1997","journal-title":"Medizinische Klinik"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0122|cit122","first-page":"707A","article-title":"Influence of diltiazem on cyclosporine metabolites in renal graft recipients treated with Sandimmun and Neoral [abstract]","volume":"8","author":"Wagner","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub2-BIB0123|cit123","first-page":"382","article-title":"Randomized prospective study of effects of ace inhibitors in renal transplantation: an analysis of safety and efficacy [abstract]","volume":"2","author":"Kawaguchi","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s101570200041","article-title":"Randomized prospective study of effects of benazepril in renal transplantation: An analysis of safety and efficacy","volume":"6","author":"Takahara","year":"2002","journal-title":"Clinical and Experimental Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/JDI-120017470","article-title":"A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis","volume":"25","author":"Trivedi","year":"2003","journal-title":"Renal Failure"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-6143.2006.01588.x","article-title":"Renal allograft protection with angiotensin II type 1 receptor antagonists","volume":"7","author":"Tylicki","year":"2007","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.tp.0000188137.50178.7d","article-title":"Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients","volume":"81","author":"Tylicki","year":"2006","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub2-BIB0128|cit128","first-page":"50","article-title":"Effect of isradipine on cyclosporin A-related hypertension","volume":"3","author":"Dorpel","year":"1994","journal-title":"Blood Pressure"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1111\/j.1432-2277.1994.tb01365.x","article-title":"Prophylactic isradipine treatment after kidney transplantation: a prospective double-blind placebo-controlled randomized trial","volume":"7","author":"Dorpel","year":"1994","journal-title":"Transplantation International"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.HYP.25.1.77","article-title":"Hypertension after renal transplantation. Calcium channel or converting enzyme blockade?","volume":"25","author":"Schaaf","year":"1995","journal-title":"Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0131|cit131","first-page":"122","article-title":"Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study","volume":"70","author":"Riemsdijk","year":"2000","journal-title":"Transplantation"},{"issue":"3 Suppl 3","key":"10.1002\/14651858.CD003598.pub2-BIB0132|cit132","first-page":"615","article-title":"Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients","volume":"20","author":"Vanrenterghem","year":"1988","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ndt\/14.2.384","article-title":"Renal effects of amlodipine in normotensive renal transplant recipients","volume":"14","author":"Venkat-Raman","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0134|cit134","unstructured":"Venkat-Raman G Griffin P Moore R Goodship T Effects of amlodipine on renal function and cyclosporine pharmacokinetics in normotensive renal transplant recipients [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain) 1995 381"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00007890-199108000-00018","article-title":"Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients","volume":"52","author":"Kunzendorf","year":"1991","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0136|cit136","first-page":"S87","article-title":"Protective effects of calcium antagonists in human renal transplantation","volume":"41","author":"Neumayer","year":"1992","journal-title":"Kidney International - Supplement"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/08860229209106631","article-title":"Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation","volume":"14","author":"Neumayer","year":"1992","journal-title":"Renal Failure"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0138|cit138","unstructured":"Neumayer HH Schreiber M Wagner K Prevention of delayed graft function by diltiazem and iloprost Transplantation Proceedings 1989 1221 4 2469225"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0139|cit139","unstructured":"Neumayer HH Schreiber M Wagner K Prevention of delayed graft function in cadaver kidney transplants by the calcium antagonist diltiazem and the prostacyclin analogue Iloprost: Outcome of a prospective randomised clinical trial [abstract] Nephrology Dialysis Transplantation 1988 572 3"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0140|cit140","unstructured":"Neumayer HH Schreiber M Wagner K Prevention of delayed graft function in cadaveric kidney transplants by the calcium antagonist diltiazem and the prostacyclin-analogue iloprost--outcome of a prospective randomized clinical trial Progress in Clinical & Biological Research 1989 289 95 2477852"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0141|cit141","first-page":"465","article-title":"Prevention of delayed graft function in cadaver kidney transplants by diltiazem [abstract]","volume":"31","author":"Neumayer","year":"1987","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1097\/00005344-198710100-00058","article-title":"Prevention of delayed graft function in cadaver kidney transplants by diltiazem: outcome of two prospective, randomized clinical trials","volume":"10 Suppl 10","author":"Neumayer","year":"1987","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0143|cit143","first-page":"141","article-title":"Does the calcium antagonist diltiazem reduce cyclosporin-A nephrotoxicity? [abstract]","volume":"1","author":"Wagner","year":"1986","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000167487","article-title":"Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study","volume":"7","author":"Wagner","year":"1987","journal-title":"American Journal of Nephrology"},{"issue":"36","key":"10.1002\/14651858.CD003598.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1055\/s-2008-1068635","article-title":"Protective effect of the calcium antagonist diltiazem on acute kidney failure following kidney transplantation. The results of a prospective randomized study","volume":"111","author":"Wagner","year":"1986","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0146|cit146","first-page":"643","article-title":"Clinical evidence for the protective role of the calcium antagonist diltiazem in acute renal failure (ARF) [abstract]","volume":"Supplement","author":"Wagner","year":"1987","journal-title":"Clinical Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0147|cit147","first-page":"171","article-title":"Effect of the calcium antagonist diltiazem on acute kidney failure following kidney transplantation. Results of 2 prospective randomized studies","volume":"82","author":"Wagner","year":"1987","journal-title":"Medizinische Klinik"},{"issue":"8468","key":"10.1002\/14651858.CD003598.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(85)92646-7","article-title":"Prevention of delayed graft function in cadaver kidney transplants by diltiazem","volume":"2","author":"Wagner","year":"1985","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0149|cit149","first-page":"311","article-title":"Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients","volume":"24","author":"Wahlberg","year":"1992","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub2-BIB0150|cit150","first-page":"150","article-title":"Candesartan attenuates angiotensin II and TGF-beta tissue expression in renal biopsies of patients with chronic allograft nephropathy [abstract]","volume":"2","author":"Wei","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD003598.pub2-BIB0151|cit151","first-page":"338","article-title":"Candesartan reduces expression of angiotensin II and TGF-beta and increases DNA repair enzyme in human chronic allograft nephropathy [abstract]","volume":"3","author":"Wei","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0152|cit152","first-page":"24A","article-title":"Candesartan reduces DNA damage and increases DNA repair enzyme in renal biopsies of patients with chronic allograft nephropathy [abstract]","volume":"13","author":"Wei","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0153|cit153","first-page":"24A","article-title":"Reduced expression of angiotensin II and TGF-beta in renal biopsies of patients with chronic allograft nephropathy by candesartan [abstract]","volume":"13","author":"Wei","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Nov","key":"10.1002\/14651858.CD003598.pub2-BIB0154|cit154","first-page":"418A","article-title":"Angiotensin receptor blockade has significant immunomodulatory effects in chronic allograft nephropathy [abstract]","volume":"14","author":"Becker","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0155|cit155","unstructured":"Becker BN Jacobson LM Muehrer RJ Hullett DA Chronic type 1 angiotensin II receptor blockade attenuates lymphocyte responsiveness in renal allograft recipients [abstract] American Journal of Transplantation 2003 309"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1523-1755.2005.00318.x","article-title":"ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro","volume":"67","author":"Weidanz","year":"2005","journal-title":"Kidney International"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD003598.pub2-BIB0157|cit157","first-page":"612","article-title":"Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients","volume":"25","author":"Wilkie","year":"1993","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD003598.pub2-BIB0158|cit158","first-page":"612","article-title":"Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients","volume":"25","author":"Wilkie","year":"1993","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0159|cit159","unstructured":"Wilkie ME Beer JC Evans C Lord RH Raftery MJ Marsh FP A prospective randomized double-blind placebo-controlled trial of oral nifedipine on early renal allograft function [abstract] 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem (Israel) 1993 156"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0160|cit160","unstructured":"Wilkie ME Beer JC Evans C Lord RH Raftery MJ Marsh FP Prospective trial of oral nifedipine on early renal allograft function [abstract] Nephrology Dialysis Transplantation 1993 1053 4"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0161|cit161","first-page":"800","article-title":"A double-blind, randomized, placebo-controlled study of nifedipine on early renal allograft function","volume":"9","author":"Wilkie","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00007890-200108150-00035","article-title":"Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study","volume":"72","author":"Yildiz","year":"2001","journal-title":"Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0163|cit163","first-page":"A302","article-title":"The effect of enalapril and losartan in posttransplant erythrocytosis [abstract]","volume":"14","author":"Yildiz","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.TP.0000148802.04879.27","article-title":"The influence of immunomodulatory diets on transplant success and complications","volume":"79","author":"Alexander","year":"2005","journal-title":"Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0165|cit165","first-page":"A70","article-title":"The antihypertensive and renal protective effects of amlodipine versus cilazapril in renal transplant recipients with hypertension [abstract]","volume":"15","author":"Almeshari","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1016\/j.transproceed.2005.09.098","article-title":"No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem","volume":"37","author":"Aros","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"700","key":"10.1002\/14651858.CD003598.pub2-BIB0167|cit167","first-page":"44","article-title":"Open comparison of diuretic effects of piretanide and bumetanide in patients with stable renal transplants","volume":"95","author":"Bailey","year":"1982","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/00369330740190S112","article-title":"The use of Lasix post-operatively in clinical renal transplantation","volume":"19 Suppl 1","author":"Bewick","year":"1974","journal-title":"Scottish Medical Journal"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0169|cit169","first-page":"82A","article-title":"Low dose ACE inhibition and glomerular permselectivity in renal transplant recipients [abstract]","volume":"8","author":"Borchhardt","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/ki.1997.494","article-title":"Low dose angiotensin converting enzyme inhibition and glomerular permselectivity in renal transplant recipients","volume":"52","author":"Borchhardt","year":"1997","journal-title":"Kidney International"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub2-BIB0171|cit171","first-page":"745","article-title":"Calcium blocker before cyclosporin A in kidney recipients [abstract]","volume":"5","author":"Bourbigot","year":"1990","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/oxfordjournals.ndt.a027840","article-title":"Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A","volume":"13","author":"Branten","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5414\/CNP58103","article-title":"Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine","volume":"58","author":"Calo","year":"2002","journal-title":"Clinical Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0174|cit174","first-page":"1054","article-title":"Immunosuppressive effects of different calcium channel blockers in human kidney allografts","volume":"27","author":"Carozzi","year":"1995","journal-title":"Transplantation Proceedings"},{"issue":"25-28","key":"10.1002\/14651858.CD003598.pub2-BIB0175|cit175","first-page":"855","article-title":"Effect of sustained release alprenolol in hypertension uncontrolled by chlorothiazide and dihydralazine. Study in double blind (author's transl)","volume":"54","author":"Cartier","year":"1978","journal-title":"Semaine des Hopitaux"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003598.pub2-BIB0176|cit176","first-page":"47","article-title":"Comparative randomized study of calcium channel blockers vs. angiotensin converting enzyme inhibitors in the treatment of hypertension under cyclosporine immunosuppression","volume":"13","author":"Castelao","year":"1993","journal-title":"Nefrologia"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1046\/j.1523-1755.1998.06826.x","article-title":"Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin","volume":"68","author":"Martinez-Castelao","year":"1998","journal-title":"Kidney International - Supplement"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0178|cit178","first-page":"2159","article-title":"Are cytochrome P450 3A enzymes in the small intestine responsible for different cyclosporine metabolite patterns in stable male and female renal allograft recipients after co-administration of diltiazem?","volume":"28","author":"Christians","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0041-1345(00)01249-5","article-title":"Influence of angiotensin-converting enzyme inhibitor treatment of the carotid artery intima-media complex in renal allograft recipients","volume":"32","author":"Cieciura","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0180|cit180","first-page":"2174","article-title":"Verapamil improves Sandimmune immunosuppression, reducing acute rejection episodes","volume":"28","author":"Citterio","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/S0041-1345(01)02186-8","article-title":"The comparison of angiotensin-converting enzyme inhibitors with calcium antagonists in renal transplant patients under cyclosporin treatment","volume":"33","author":"Colak","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1681\/ASN.V391570","article-title":"Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients","volume":"3","author":"Curtis","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub2-BIB0183|cit183","first-page":"567","article-title":"Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline","volume":"45","author":"D'Amelio","year":"1997","journal-title":"Minerva Cardioangiologica"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0184|cit184","first-page":"575","article-title":"Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil","volume":"48","author":"Dawidson","year":"1989","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0185|cit185","first-page":"3100","article-title":"Perioperative albumin and verapamil improve early outcome after cadaver renal transplantation","volume":"26","author":"Dawidson","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0041-1345(01)02806-8","article-title":"Losartan reduces massive proteinuria in kidney transplant patients: a pilot study","volume":"34","author":"Dominguez-Gil","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1016\/S0041-1345(99)00736-8","article-title":"The effects of diltiazem and dopamine on early graft function in renal transplant recipients","volume":"31","author":"Donmez","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0188|cit188","first-page":"289","article-title":"Verapamil prevents post-transplant oliguric renal failure","volume":"24","author":"Duggan","year":"1985","journal-title":"Clinical Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0189|cit189","first-page":"2187","article-title":"Beneficial effects of verapamil in renal transplantation","volume":"25","author":"Erken","year":"1993","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0190|cit190","first-page":"2600","article-title":"Enalapril and cyclosporin in renal transplant patients and rats","volume":"26","author":"Ferguson","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/S0041-1345(99)00733-2","article-title":"Efficacy and safety of losartan in renal transplant recipients","volume":"31","author":"Hadjigavriel","year":"1999","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0192|cit192","unstructured":"Hetzel GR Schmitz M Plum J Voiculescu A Grabensee B Effects of candesartan on glomerular function in patients within the first year after renal transplantation [abstract] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon (Portugal) 2004 200 1"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0041-1345(98)00562-4","article-title":"Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis","volume":"30","author":"Hortal","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/S0041-1345(99)00359-0","article-title":"Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis","volume":"31","author":"Inigo","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0041-1345(02)03787-9","article-title":"Beneficial effect of losartan against proteinuria from the renal allograft","volume":"35","author":"Ishikawa","year":"2003","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003598.pub2-BIB0196|cit196","first-page":"320","article-title":"Effect of losartan and temocapril on plasma plasminogen activator inhibitor-1 in cyclosporine-treated renal allograft recipients [abstract]","volume":"5","author":"Ishikawa","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1016\/S0041-1345(99)00702-2","article-title":"Management of posttransplant erythrocytosis with enalapril","volume":"31","author":"Javid","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"1-2","key":"10.1002\/14651858.CD003598.pub2-BIB0199|cit198","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0041-1345(00)02385-X","article-title":"Uricosuric effect of losartan in renal transplanted patients","volume":"33","author":"Kamper","year":"2001","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0198|cit199","doi-asserted-by":"crossref","unstructured":"Kamper A Nielsen AH Uricosuric effect of losartan in renal transplanted patients [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sept 1; Rome (Italy) 2000","DOI":"10.1016\/S0041-1345(00)02385-X"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00007890-200108270-00019","article-title":"Uricosuric effect of losartan in patients with renal transplants","volume":"72","author":"Kamper","year":"2001","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0201|cit201","first-page":"311","article-title":"Platelet inhibitors in human renal homotransplantation: randomized comparison of aspirin versus dipyridamole","volume":"12","author":"Kauffman","year":"1980","journal-title":"Transplantation Proceedings"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/S0041-1345(02)03688-6","article-title":"Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients","volume":"34","author":"Kim","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0203|cit203","first-page":"905","article-title":"Does systemic pretreatment with verapamil prevent acute tubular necrosis after renal transplantation?","volume":"20","author":"Koller","year":"1988","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0204|cit204","first-page":"A227","article-title":"Long term effects of two ace inhibitors on erythropoiesis in renal transplantation [abstract]","volume":"12","author":"Konstadinidou","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"22","key":"10.1002\/14651858.CD003598.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/BF01736117","article-title":"Effect of diltiazem on blood cyclosporin levels","volume":"65","author":"Kunzendorf","year":"1987","journal-title":"Klinische Wochenschrift"},{"issue":"1-2","key":"10.1002\/14651858.CD003598.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0041-1345(96)00065-6","article-title":"Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients","volume":"29","author":"Kupin","year":"1997","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/039139889501800104","article-title":"Long term effects of ACE inhibitors on the erythrocytosis in renal transplant recipients","volume":"18","author":"Lal","year":"1995","journal-title":"International Journal of Artificial Organs"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/00005344-199311000-00006","article-title":"Systemic and renal hemodynamic responses to carvedilol and metoprolol in hypertensive renal transplant patients","volume":"22","author":"Leeman","year":"1993","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11906-005-0085-1","article-title":"BENEDICT in the treatment of hypertension","volume":"7","author":"Logan","year":"2005","journal-title":"Current Hypertension Reports"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11906-005-0044-x","article-title":"Does ALLHAT change the management of hypertension in chronic kidney disease?","volume":"7","author":"MacKinnon","year":"2005","journal-title":"Current Hypertension Reports"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/00365519509110262","article-title":"Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone","volume":"55","author":"Madsen","year":"1995","journal-title":"Scandinavian Journal of Clinical & Laboratory Investigation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0212|cit212","unstructured":"Madsen JK Zachariae H Pedersen EB Beneficial effects of felodipine on renal hemodynamics, tubular sodium handling, and blood pressure in cyclosporine-treated dermatological patients [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain) 1995 36"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0213|cit213","first-page":"401","article-title":"Enalapril effectively treats diabetic and non-diabetic renal allograft recipients with post-transplant hypertension [abstract]","volume":"37","author":"Markell","year":"1990","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.intimp.2004.09.025","article-title":"Vasodilatation vs. immunotherapy to prevent delayed graft function: delayed graft function as an indication of immune activation","volume":"5","author":"McCune","year":"2005","journal-title":"International Immunopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0041-1345(98)00381-9","article-title":"Study of neoral kinetics in adult renal transplantation treated with diltiazem","volume":"30","author":"Mezzano","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD003598.pub2-BIB0216|cit216","first-page":"47","article-title":"Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms","volume":"53","author":"Montanaro","year":"2000","journal-title":"Clinical Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.transproceed.2005.01.043","article-title":"Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients","volume":"37","author":"Montanaro","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0218|cit218","first-page":"A205","article-title":"Comparative studies of renal hemodynamics and function in renal transplant recipients (RTR) treated by cyclosporine (CS) or tacrolimus (TC) [abstract]","volume":"12","author":"Mourad","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0041-1345(00)00886-1","article-title":"Increased incidence of infection in verapamil-treated kidney transplant recipients","volume":"32","author":"Nanni","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub2-BIB0220|cit220","first-page":"1221","article-title":"Prevention of delayed graft function by diltiazem and iloprost","volume":"21","author":"Neumayer","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0221|cit221","first-page":"572","article-title":"Prevention of delayed graft function in cadaver kidney transplants by the calcium antagonist diltiazem and the prostacyclin analogue Iloprost: Outcome of a prospective randomised clinical trial [abstract]","volume":"3","author":"Neumayer","year":"1988","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0222|cit222","first-page":"289","article-title":"Prevention of delayed graft function in cadaveric kidney transplants by the calcium antagonist diltiazem and the prostacyclin-analogue iloprost--outcome of a prospective randomized clinical trial","volume":"301","author":"Neumayer","year":"1989","journal-title":"Progress in Clinical & Biological Research"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/00007890-198906000-00032","article-title":"A controlled trial of dipyridamole as an immunomodulator in renal allograft recipients","volume":"47","author":"Niyamathullah","year":"1989","journal-title":"Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1399-0012.1997.tb00800.x","article-title":"A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft","volume":"11","author":"Noel","year":"1997","journal-title":"Clinical Transplantation"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub2-BIB0225|cit225","first-page":"1705","article-title":"Cyclosporin A and hypertension in pediatric renal transplant recipients","volume":"21","author":"Ogborn","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0226|cit226","first-page":"87","article-title":"Hemodynamic effects of amrinone combined with dopamine in patients undergoing living renal transplantation","volume":"46","author":"Okuno","year":"1997","journal-title":"Masui - Japanese Journal of Anesthesiology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0227|cit227","first-page":"87","article-title":"Comparative analysis of kidney preservation methods. Collaborative Transplant Study","volume":"28","author":"Opelz","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0228|cit228","first-page":"2235","article-title":"Treatment with angiotensin-converting enzyme inhibitors in renal transplantation with proteinuria","volume":"27","author":"Oppenheimer","year":"1995","journal-title":"Transplantation Proceedings"},{"issue":"11-12","key":"10.1002\/14651858.CD003598.pub2-BIB0229|cit229","first-page":"378","article-title":"Hypertension in patients with renal transplantation","volume":"128","author":"Orlic","year":"2006","journal-title":"Lijecnicki Vjesnik"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0230|cit230","first-page":"932","article-title":"Intraglomerular cathepsin B and L activity in chronic kidney allograft rejection","volume":"27","author":"Paczek","year":"1995","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0231|cit231","first-page":"2602","article-title":"Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft","volume":"26","author":"Pisani","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0232|cit232","first-page":"2213","article-title":"Preliminary results of the European Multicenter Trial of UW and Euro-Collins solutions in kidney transplantation. The Study Group","volume":"22","author":"Ploeg","year":"1990","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0233|cit233","first-page":"956","article-title":"Effect of varying doses of enalapril on post-transplant erythocytosis [abstract]","volume":"4","author":"Po","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0234|cit234","first-page":"1030","article-title":"Long term effects of calcium channel blockers on proteinuria in renal transplant patients on cyclosporine [abstract]","volume":"5","author":"Po","year":"1994","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0235|cit235","first-page":"494","article-title":"Allogeneic sensitization alters T-cell reactivity to extracellular matrix proteins in prospective transplant recipients","volume":"27","author":"Podobinska","year":"1995","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"M610","DOI":"10.1097\/00002480-199809000-00062","article-title":"Prostaglandin E1 improves pulsatile preservation characteristics and early graft function in expanded criteria donor kidneys","volume":"44","author":"Polyak","year":"1998","journal-title":"ASAIO Journal"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0237|cit237","first-page":"52","article-title":"A multivariate analysis of the risk factors for posttransplant renal failure: beneficial effect of a flush solution with mannitol","volume":"24","author":"Porras","year":"1992","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub2-BIB0238|cit238","first-page":"2368","article-title":"Usefulness of diltiazem in reducing the incidence of acute tubular necrosis in Euro-Collins-preserved cadaveric renal grafts","volume":"23","author":"Puig","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0239|cit239","first-page":"1555","article-title":"Preventive effect of enalapril on erythrocytosis after renal transplantation","volume":"28","author":"Rhee","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub2-BIB0240|cit240","first-page":"1228","article-title":"Mannitol reduces ATN in cadaveric allografts","volume":"21","author":"Richards","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0241|cit241","first-page":"877","article-title":"Does enalapril retard the progression of renal insufficiency in kidney transplant recipients? [abstract]","volume":"3","author":"Riggio","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD003598.pub2-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s004670000400","article-title":"A randomized prospective crossover trial of amlodipine in pediatric hypertension","volume":"14","author":"Rogan","year":"2000","journal-title":"Pediatric Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/clpt.1989.202","article-title":"Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients","volume":"46","author":"Roy","year":"1989","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/ki.1993.101","article-title":"Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion","volume":"43","author":"Ruggenenti","year":"1993","journal-title":"Kidney International"},{"issue":"5-6","key":"10.1002\/14651858.CD003598.pub2-BIB0245|cit245","first-page":"331","article-title":"Study on the evaluation of candesartan cilexetil after renal transplantation (SECRET Study [abstract]","volume":"27","author":"Philipp","year":"2004","journal-title":"Kidney & Blood Pressure Research"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0246|cit246","first-page":"1309","article-title":"Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation","volume":"28","author":"Shin","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub2-BIB0247|cit247","first-page":"1230","article-title":"A prospective randomized study of the protective effect of verapamil on ischemic renal injury in renal allotransplants","volume":"21","author":"Sobh","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub2-BIB0248|cit248","first-page":"833","article-title":"Renal haemodynamic and tubular effects of felodipine in cyclosporin-treated renal transplant recipients [abstract]","volume":"6","author":"Sorensen","year":"1991","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/00005344-199100181-00019","article-title":"Cardiovascular side effects after renal allograft rejection therapy with Orthoclone: prevention with nitrendipine","volume":"18 Suppl 1","author":"Spieker","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0250|cit250","first-page":"540","article-title":"Effects of ace inhibitors and beta-blockers on arterial compliance [abstract]","volume":"4","author":"Spieker","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub2-BIB0251|cit251","first-page":"964","article-title":"Use of angiotensin converting enzyme inhibitors in the post transplant period: prospective study [abstract]","volume":"4","author":"Stempel","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0252|cit252","first-page":"1557","article-title":"Effect of captopril in the treatment of erythrocytosis after renal transplantation","volume":"28","author":"Suh","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub2-BIB0253|cit253","first-page":"1334","article-title":"Kidney protective effect of diltiazem after renal transplantation with long cold ischemia time and triple-drug immunosuppression","volume":"23","author":"Tenschert","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub2-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/S0041-1345(98)00935-X","article-title":"Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis","volume":"30","author":"Tsang","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub2-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/ndt\/13.10.2612","article-title":"Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients","volume":"13","author":"Venkat-Raman","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0041-1345(00)01266-5","article-title":"Effects of pentoxifylline treatment on delayed graft function in cadaveric kidney recipients","volume":"32","author":"Wlodarczyk","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1016\/j.transproceed.2005.10.122","article-title":"Clinical study of Lipo PGE1-inhibiting platelet activation in acute rejection after kidney transplantation","volume":"37","author":"Zhang","year":"2005","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0258|cit258","unstructured":"Ibrahim HN Angiotensin II Blockade for the prevention of cortical interstitial expansion and graft loss in kidney transplant recipients ClinincalTrials.gov 2008"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ndt\/gfm574","article-title":"The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design","volume":"23","author":"Knoll","year":"2008","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0260|cit260","unstructured":"Rustom R Does lisinopril protect transplanted kidneys with chronic vascular rejection (CR) from progressive failure Current Controlled Trials"},{"issue":"Abstracts","key":"10.1002\/14651858.CD003598.pub2-BIB0261|cit261","first-page":"548A","article-title":"Angiotensin receptor blocker's effect on hemoglobin in renal transplant patients - an interim analysis of the specific management of anemia and hypertension in renal transplant recipients trial (SMAhRT) [abstract]","volume":"17","author":"Weinstein","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-200868001-00005","article-title":"Mechanisms and management of proteinuria in kidney transplant patients","volume":"68 Suppl 1","author":"Barama","year":"2008","journal-title":"Drugs"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub2-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1592\/phco.23.6.788.32180","article-title":"Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: fact or fiction","volume":"23","author":"Baroletti","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2215\/CJN.04641007","article-title":"Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection","volume":"3","author":"Chhabra","year":"2008","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0265|cit265","unstructured":"Thompson Healthcare Ciclosporin DRUGDEX(R) Evaluation (accessed November 2008)"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1432-2277.2008.00638.x","article-title":"The renin angiotensin system blockade in kidney transplantation: pros and cons","volume":"21","author":"Cruzado","year":"2008","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0267|cit267","first-page":"S75","article-title":"Treatment of hypertension in renal allograft patients: does drug selection make a difference?","volume":"63","author":"Curtis","year":"1997","journal-title":"Kidney International - Supplement"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub2-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000070864","article-title":"Death with functioning graft in living donor kidney transplantation: analysis of risk factors","volume":"23","author":"El-Agroudy","year":"2003","journal-title":"American Journal of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0271|cit271","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub2-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data","volume":"135","author":"Jafar","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD003598.pub2-BIB0274|cit274","first-page":"1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2004","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","article-title":"Cardiovascular disease after renal transplantation","volume":"7","author":"Kasiske","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub2-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V1191735","article-title":"Explained and unexplained ischemic heart disease risk after renal transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"6 Suppl 6","key":"10.1002\/14651858.CD003598.pub2-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1053\/ajkd.2001.28924","article-title":"Cardiovascular disease and the renal transplant recipient","volume":"38","author":"Kendrick","year":"2001","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-148-1-200801010-00190","article-title":"Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease","volume":"148","author":"Kunz","year":"2008","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/08860220801947686","article-title":"MDRD-estimated GFR at one year post-renal transplant is a predictor of long-term graft function","volume":"30","author":"Lenihan","year":"2008","journal-title":"Renal Failure"},{"issue":"9638","key":"10.1002\/14651858.CD003598.pub2-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub2-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1111\/j.1440-1797.2006.00616.x","article-title":"The CARI guidelines. Prevention of progression of kidney disease. ACE inhibitor treatment in diabetic nephropathy","volume":"11","author":"Nicholls","year":"2006","journal-title":"Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","article-title":"Association of chronic kidney graft failure with recipient blood pressure","volume":"53","author":"Opelz","year":"1998","journal-title":"Kidney International"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub2-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report","volume":"17","author":"Opelz","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.0000151805.86933.35","article-title":"Drug therapy in the heart transplant recipient: part IV: drug-drug interactions","volume":"111","author":"Page","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub2-BIB0286|cit286","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006257","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease","author":"Strippoli","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0287|cit287","unstructured":"Taal MW Tomson C UK Renal Association Clinical Practice Guidelines. Module 1: Chronic Kidney Disease http:\/\/www.renal.org\/pages\/media\/download_gallery\/CKDglinesreformatjan08.pdf (accessed May 2009)"},{"key":"10.1002\/14651858.CD003598.pub2-BIB0288|cit288","unstructured":"Thompson Healthcare Tacrolimus DRUGDEX(R) Evaluation (accessed November 2008)"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub2-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub2-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/TP.0b013e3181a9e960","article-title":"Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials","volume":"88","author":"Cross","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub2-BIB0291|cit291","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003598","article-title":"Antihypertensive treatment for kidney transplant recipients","author":"Risler","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003598.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003598.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T17:30:14Z","timestamp":1739208614000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003598.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,7,8]]},"references-count":291,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003598.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,8]]}}}